Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Garg, A.
space
  arrow  Guyatt, G.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

REVIEW

The Ineffectiveness of Immunosuppressive Therapy in Lymphocytic Myocarditis: An Overview

right arrow Amit Garg, MD; Judy Shiau, MDCM; and Gordon Guyatt, MD, MSc

15 August 1998 | Volume 129 Issue 4 | Pages 317-322

Background: The use of immunosuppressive therapy for myocarditis is controversial.

Purpose: To review the literature on the effectiveness of immunosuppressive therapy in biopsy-proven lymphocytic myocarditis.

Data Sources: Two authors independently searched MEDLINE and other medical databases from 1980 to 26 June 1997.

Study Selection: Randomized, controlled trials; matched-cohort studies; and case–control studies of patients with biopsy-proven myocarditis (Dallas criteria or a mean of ≥ 2.5 lymphocytes per high-power field) for which any form of immunosuppressive treatment was used. The outcomes of interest were mortality and change in left ventricular ejection fraction.

Data Extraction: 6 of 374 studies satisfied the selection criteria.

Data Synthesis: In survivors, left ventricular function in myocarditis improved approximately 10% over 6 months without immunosuppressive treatment. Prednisone alone did not improve survival (P >0.2) or left ventricular function (P >0.11). Prednisone combined with azathioprine or cyclosporine did not improve survival (P >0.2) or left ventricular function (P >0.2) in three studies. However, one small matched-cohort study showed improvement in children (P <0.01). Neither interferon nor thymic hormone improved survival or left ventricular function.

Conclusions: Immunosuppressive therapy is ineffective in lymphocytic myocarditis. Current therapy in lymphocytic myocarditis seems to be limited to supportive measures or transplantation.

Author and Article Information
space

From McMaster University, Hamilton, Ontario, Canada
Acknowledgments: The authors thank R. Garg, PhD; B. Maisch, MD; F. Moniz, MD; P. Powles, MD; and P. Tanser, MD.
Requests for Reprints: Judy Shiau, MDCM, Department of Medicine, McMaster University, Room 3W10 B, Health Sciences Centre, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada; e-mail, shiauj@fhs.mcmaster.ca.
Current Author Addresses: Drs. Garg, Shiau, and Guyatt: Department of Medicine, McMaster University, Room 3W10 B, Health Sciences Centre, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada.




This article has been cited by other articles:


Home page
HeartHome page
N Amabile, A Fraisse, J Bouvenot, P Chetaille, and C Ovaert
Outcome of acute fulminant myocarditis in children
Heart, September 1, 2006; 92(9): 1269 - 1273.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M Burch
Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence
Heart, October 1, 2004; 90(10): 1103 - 1104.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
C P P Hia, W C L Yip, B C Tai, and S C Quek
Immunosuppressive therapy in acute myocarditis: an 18 year systematic review
Arch. Dis. Child., June 1, 2004; 89(6): 580 - 584.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1998 by the American College of Physicians.